Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast

INTRODUCTION: To investigate the predictive value of clinical and biological markers for a pathological complete remission after a preoperative dose-dense regimen of doxorubicin and docetaxel, with or without tamoxifen, in primary operable breast cancer. METHODS: Patients with a histologically confi...

Descripción completa

Detalles Bibliográficos
Autores principales: von Minckwitz, Gunter, Sinn, Hans-Peter, Raab, Günter, Loibl, Sibylle, Blohmer, Jens-Uwe, Eidtmann, Holger, Hilfrich, Jörn, Merkle, Elisabeth, Jackisch, Christian, Costa, Serban D, Caputo, Angelika, Kaufmann, Manfred
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2397529/
https://www.ncbi.nlm.nih.gov/pubmed/18380893
http://dx.doi.org/10.1186/bcr1989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2397529/
https://www.ncbi.nlm.nih.gov/pubmed/18380893
http://dx.doi.org/10.1186/bcr1989

Ejemplares similares